Casdin Private Growth Equity Fund GP, LLC just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13D. In the filing, it appears as though Casdin Private Growth Equity Fund GP, LLC claims to own 56,297,042 shares. This represents 11.5% of CM Life Sciences III Inc..
Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.
To receive a free e-mail notification whenever CM Life Sciences III Inc. makes a similar move, sign up!